Human Milk Oligosaccharides (HMO Market: Innovations and Advancements in Technology to Boost Market Growth

According to a new report published by Allied Market Research, titled "Human Milk Oligosaccharides (HMOs) Market by Type, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2028, the global human milk oligosaccharides (HMO) market size was valued at $125.9 million in 2020 and is estimated to reach $332.6 million by 2028, registering a CAGR of 14.1% from 2021 to 2028.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/request-sample/A12027

Human milk oligosaccharide (HMO) has emerged as a vital component in promoting gut health, especially among infants. As a prebiotic, it fosters the growth of beneficial bacteria, particularly in the Bifidobacterium genus, which contributes to metabolic activities crucial for health. Its antimicrobial and prebiotic properties have led to its inclusion in various foods, including pharmaceuticals, medicinal foods, and infant formulas.

Being the third most abundant solid nutrient in human breast milk after lactose and fats, HMOs play a pivotal role in enhancing infant health by supporting immune development, neurodevelopment, and digestion. Moreover, they hold promise for benefiting adults as well. Commercially manufactured HMOs can replicate some of the nutritional effects found in human milk, facilitating their inclusion in a wider array of products.

Fermented HMOs have revolutionized the production of infant formula, making it more akin to human milk, thus enabling formula-fed infants to derive essential components similar to breastfed babies. HMOs serve multiple primary functions, including infection prevention, prebiotic effects, and the provision of sialic acid, which is crucial for brain growth. However, infant formula derived from bovine milk contains lower levels of oligosaccharides compared to human milk, prompting researchers to explore techniques such as extracting HMOs from cow milk using sophisticated methods or synthesizing them using microbial processes.

The current trends in the Human Milk Oligosaccharides (HMO) market indicate a robust demand trajectory, driven by the increasing number of health-conscious individuals globally and growing awareness about the benefits of HMOs. Factors such as rising consumer concerns regarding health stability and the uptake of food and dietary supplements have propelled exponential growth in the HMO market.

In recent years, a multitude of players have entered the global HMO market, resulting in diverse HMO products with varying nutritional content available through numerous distribution channels. Additionally, the digital revolution has provided brands with new avenues for promoting their products, further fueling market growth. While the HMO market remains competitive, participants are expected to focus on packaging, pricing, and marketing strategies to gain a competitive edge.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐏𝐫𝐢𝐜𝐢𝐧𝐠 𝐃𝐞𝐭𝐚𝐢𝐥𝐬 : https://www.alliedmarketresearch.com/human-milk-oligosaccharides-hmo-market/purchase-options

Market segmentation for HMOs is based on type, application, distribution channel, and region. The types include 2'FL, 3'FL, 3'SL, and 6'SL, with applications spanning infant formula, functional food & beverage, and food supplements. Distribution channels encompass hypermarkets & supermarkets, drug stores or pharmacies, mass merchandisers, department stores, mono-brand stores, specialty stores, and online sales channels. Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

In 2020, the 2'FL segment accounted for the highest revenue, driven by its ability to protect against infectious diseases by preventing toxins and pathogens from adhering to epithelial cells. Infant formula emerged as the dominant application segment due to the beneficial properties of HMOs in supporting memory formation and cognitive performance, which are crucial for infant growth and development. Drug stores or pharmacies led the distribution channel segment, emphasizing convenience factors to attract and retain customers.

The accelerated demand for HMOs in infant formula owing to global concerns about nutrition and premature mortality presents a significant market opportunity. HMOs' prebiotic properties, potential to enhance memory and brain growth, and high nutritional value are key drivers of market growth. Additionally, breast milk's ability to shield babies from infections and allergic reactions is expected to further propel market expansion, as it offers long-term protection against various health conditions.

The introduction of new products tailored to address specific health issues, such as diabetes and indigestion, is anticipated to drive market growth further. Leading manufacturers are already focusing on offering products targeting specific health and wellness categories, such as digestion and cognitive enhancement. As such trends gain momentum, they are expected to significantly influence the expanding functional food & beverage market, thereby strengthening brand equity.

However, the production of HMOs faces challenges, primarily due to the scarcity of donor groups required for direct synthesis from human milk. Current manufacturing methods involve chemical and enzyme synthesis, necessitating substantial investments of time and resources, which ultimately limits the scale of production. Moreover, functional alternatives such as fructooligosaccharides and galactooligosaccharides, prevalent in infant formula, pose a competitive threat due to their lower cost and widespread availability.

𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 : https://www.alliedmarketresearch.com/purchase-enquiry/A12027

𝐓𝐨 𝐧𝐚𝐯𝐢𝐠𝐚𝐭𝐞 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞, 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐇𝐌𝐎 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐚𝐫𝐞 𝐞𝐦𝐩𝐥𝐨𝐲𝐢𝐧𝐠 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐬𝐮𝐜𝐡 𝐚𝐬 𝐩𝐫𝐨𝐝𝐮𝐜𝐭 𝐋𝐚𝐮𝐧𝐜𝐡𝐞𝐬

→ 𝐌𝐞𝐫𝐠𝐞𝐫𝐬 & 𝐀𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧𝐬
→ 𝐣𝐨𝐢𝐧𝐭 𝐯𝐞𝐧𝐭𝐮𝐫𝐞𝐬
→ 𝐠𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧𝐬.

𝐊𝐞𝐲 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬 𝐢𝐧𝐜𝐥𝐮𝐝𝐞

→ 𝐀𝐛𝐛𝐨𝐭𝐭 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬
→ 𝐁𝐀𝐒𝐅 𝐒.𝐄.
→ 𝐁𝐢𝐨𝐬𝐲𝐧𝐭𝐡 𝐂𝐚𝐫𝐛𝐨𝐬𝐲𝐧𝐭𝐡
→ 𝐂𝐡𝐫. 𝐇𝐚𝐧𝐬𝐞𝐧 𝐇𝐨𝐥𝐝𝐢𝐧𝐠 𝐀/𝐒
→ 𝐃𝐞𝐱𝐭𝐫𝐚 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬 𝐋𝐭𝐝.
→ 𝐃𝐮𝐩𝐨𝐧𝐭 𝐍𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧 & 𝐁𝐢𝐨𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬
→ 𝐄𝐥𝐢𝐜𝐢𝐭𝐲𝐥 𝐒.𝐀.
→ 𝐆𝐥𝐲𝐜𝐨𝐦 𝐀/𝐒
→ 𝐆𝐥𝐲𝐜𝐨𝐬𝐲𝐧
→ 𝐈𝐧𝐛𝐢𝐨𝐬𝐞 𝐍𝐕
→ 𝐌𝐞𝐝𝐨𝐥𝐚𝐜 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐢𝐞𝐬
→ 𝐍𝐞𝐨𝐥𝐚𝐜𝐭𝐚 𝐋𝐢𝐟𝐞𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐏𝐯𝐭. 𝐋𝐭𝐝
→ 𝐍𝐞𝐬𝐭𝐥𝐞 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐜𝐢𝐞𝐧𝐜𝐞
→ 𝐑𝐨𝐲𝐚𝐥 𝐃𝐒𝐌
→ 𝐙𝐮𝐂𝐡𝐞𝐦.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (toll-free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/food-and-beverages
Follow Us on Blog: https://www.dailyreportsworld.com/

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view of providing business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domain.

We have professional corporate relations with various companies and this helps us dig out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high-quality of data and help clients in every way possible to achieve success. Each and every piece of data presented in the reports published by us is extracted through primary interviews with top officials from leading companies in domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.